19/01/2013 00:27:00

Johnson & Johnson in Talks for Hip Implant Settlement -Bloomberg

Related content
Related debate
13 May - 
We offer fresh cut bank instrument for lease/sale, such..
29 Mar - 
Dear Sir/Ma, We have direct providers for BG/SBLC speci..

Johnson & Johnson (JNJ) is in talks to settle litigation over recalled hip implants, Bloomberg News reported Friday, citing five people familiar with the matter.

The settlement could total more than $2 billion if most plaintiffs accept the terms, Bloomberg reported.

According to the report, J&J has offered to pay more than $200,000 per case, while lawyers for plaintiffs have said the offer is too low.

Full story at http://www.bloomberg.com/news/2013-01-18/j-j-said-to-offer-implant-pact-that-may-reach-2-billion.html

Write to nymonitoring@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

January 18, 2013 19:27 ET (00:27 GMT)

Copyright (c) 2013 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

Voting report relating to Talvivaara's draft restructuring programme submitted to the District Court

25/05/2015 13:06:21
Stock Exchange Release Talvivaara Mining Company Plc 25 May 2015 Voting report relating to Talvivaara's draft restructuring programme..

Notification of Transactions of Directors

22/05/2015 15:32:07
Intermediate Capital Group plc (the "Company") 22 May 2015 Notification of Transactions of Directors In accordance with the UK Financial Services Aut..

Holding(s) in Company

22/05/2015 13:38:48
For filings with the FSA include the annex   For filings with issuer..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Sonoco-Alcore to Increase Paperboard Prices in Italy
2
Derivatives – New Strikes Stock Products 99/15
3
Statement by the Board of Directors of PartnerTech in relation to Scanfil’s public offer
4
Stora Enso utilizes Metso's valve know-how in its Varkaus Mill rebuild in Finland
5
AB Science announces issuance of a new U.S. patent for masitinib in the treatment of severe persistent asthma

Related stock quotes

Johnson & Johnson 101.35 -1.0% Stock price decreasing

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2015   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 May 2015 00:24:09
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20150519.1 - EUROWEB6 - 2015-05-26 01:24:09 - 2015-05-26 00:24:09 - 1000 - Website: OKAY